Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

AGI Dermatics

1985 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
Description

Provider of skin diseases and DNA repair treatment solutions. The company was engaged in skin photobiology, dedicating research and development to DNA repair, solar impact on the immune system and its proprietary brand, Remergent(R).

Website
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Acquirer
Estee Lauder
Primary Office
  • 205 Buffalo Avenue
  • Freeport, NY 11520
  • United States

+1 (516) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore AGI Dermatics’s full profile, request a free trial.

AGI Dermatics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 30-Sep-2008 000 Completed Product Development
1. Early Stage VC (Series A) 08-Apr-2008 000 000 0000 Completed Product Development
To view this company’s complete deal history including valuation and funding, request access »

AGI Dermatics Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Spring Mountain Capital Growth/Expansion Minority 000 0000 000000 0
Trevi Health Capital Growth/Expansion Minority 000 0000 000000 0
WHI Group Other Minority 000 0000 000000 0